MA28192A1 -
NOVEL β-CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
- Google Patents
NOVEL β-CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
Info
Publication number
MA28192A1
MA28192A1MA28163AMA28163AMA28192A1MA 28192 A1MA28192 A1MA 28192A1MA 28163 AMA28163 AMA 28163AMA 28163 AMA28163 AMA 28163AMA 28192 A1MA28192 A1MA 28192A1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier LabfiledCriticalServier Lab
Priority to MA28163ApriorityCriticalpatent/MA28192A1/en
Publication of MA28192A1publicationCriticalpatent/MA28192A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
NOUVELLE FORME CRISTALLINE p DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT Forme cristalline p du composé de formule (I) : caractérisée par son diagramme de diffraction X sur poudre. Médicaments.NOVEL CRYSTALLINE FORM P OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, ITS PREPARATION METHOD, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Crystal form p of the compound of formula (I): characterized by its powder X-ray diffraction pattern. Drugs.
MA28163A2005-03-182005-03-18
NOVEL β-CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MA28192A1
(en)
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME